Evaluation of the Measurement of Cardiac Output by the NEXFIN HD Monitor in Peroperative
NCT ID: NCT03114579
Last Updated: 2017-04-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2015-02-11
2017-02-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The monitors usually used in perioperative are either semi-invasive and difficult for calibration (oesophageal Doppler) or invasive (arterial catheter).
The Nexfin HD allows these two measurements and it is completely non-invasive, remains to validate its use in peroperative.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Assessment of Arterial Blood Pressure and Functional Hemodynamic Parameters
NCT01292759
Comparison of Cardiac Output Measurement Between Transpulmonary Thermodilution and Photoplethysmography
NCT01535703
Assessments of Dynamic Variables of Fluid Responsiveness to Predict Desufflation-induced Hypotension in Urologic Patients Undergoing Laparoscopic Surgery
NCT03967119
Individualized Hemodynamic Optimization by Indirect Measurement of the Respiratory Quotient in Major Surgery: Prospective Randomized Multicentre Open-Label Study (OPHIQUE) Individualized Optimization by Indirect Measurement of the Respiratory Quotient
NCT03852147
Prediction of Hemodynamic Instability in Patients Undergoing Surgery
NCT03533205
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Measure of the cardiac output obtained by a reference methode
Intraoperative heart rate measurement (reference method)
Measurement of cardiac output by both monitors: NEXFIN HD and oesophageal doppler, blood pressure measurement by the catheter and NEXFIN HD monitor, and cardiac output and blood pressure measurements after treatment administration (vasoconstrictor or filling)
Measurement of cardiac output obtained by NEXFIN HD.
NEXFIN HD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intraoperative heart rate measurement (reference method)
Measurement of cardiac output by both monitors: NEXFIN HD and oesophageal doppler, blood pressure measurement by the catheter and NEXFIN HD monitor, and cardiac output and blood pressure measurements after treatment administration (vasoconstrictor or filling)
NEXFIN HD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* patients for whom access to the head is impossible,
* facial trauma patients,
* patients with aortic malformation, dilation or coarctation,
* patients with aortic dissection,
* patients with vascular surgery with aortic clamping,
* patients with a tumor, stenosis or varices of the esophagus,
* patients with severe oesophagitis,
* patients with thoracic radiotherapy
* patients under guardianship or curatorship or deprived of liberty.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens Picardie
Amiens, Picardie, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2014_843_0005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.